Drug Profile
Amniotic cell therapy - NuCel
Alternative Names: Human amniotic allograft; NuCel; ReNu™Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator NuCel
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Bone disorders
- Phase II Intervertebral disc degeneration
Most Recent Events
- 21 Feb 2014 OhioHealth & NuCel initiate enrolment in a phase II trial for Intervertebral disc degeneration in USA (NCT02070484)
- 27 Dec 2013 Phase-II clinical trials in Intervertebral disc degeneration in USA (Intralumbar)
- 01 Jan 2009 Launched for Bone disorders in USA (Perilesional)